SPECIAL APPROACHES TO BREAST CANCER HORMONAL THERAPY OF YOUNG PATIENTS
- Authors: Kravchenko DN1, Parokonnaya AA1, Nechushkin MI1, Avtomonov DE1
-
Affiliations:
- ФГБУ «Российский Онкологический Научный Центр им. Н.Н. Блохина» Минздрава России
- Issue: Vol 7, No 2 (2016)
- Pages: 15-20
- Section: Articles
- URL: https://bakhtiniada.ru/clinpractice/article/view/8093
- DOI: https://doi.org/10.17816/clinpract7215-20
- ID: 8093
Cite item
Full Text
Abstract
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
D N Kravchenko
ФГБУ «Российский Онкологический Научный Центр им. Н.Н. Блохина» Минздрава России
Email: juramento@yandex.ru
A A Parokonnaya
ФГБУ «Российский Онкологический Научный Центр им. Н.Н. Блохина» Минздрава России
Email: ANAPAR1@yandex.ru
врач онколог-маммолог, д.м.н.
M I Nechushkin
ФГБУ «Российский Онкологический Научный Центр им. Н.Н. Блохина» Минздрава Россиируководитель отделения радиохирургии, д.м.н., профессор
D E Avtomonov
ФГБУ «Российский Онкологический Научный Центр им. Н.Н. Блохина» Минздрава России
Email: dgino@yandex.ru
врач-онколог, к.м.н.
References
- DeSantis C, Siegel R, Bandi P, et al. Breast cancer statistics, 2011. CA Cancer J Clin 2011;61:409-18.
- Francis P. Optimal adjuvant therapy for very young breast cancer patients. Breast. 2011 Aug; 20(4): 297-302.
- Torino F., Barnabei A., de Vecchis L., et al. Chemotherapy-induced ovarian toxicity in patients affected by endocrine-responsive early breast cancer Crit Rev Oncol Hematol. 2014 Jan;89(1):27-42.
- Taylor C.W., Green S., Dalton W.S. Multicenter randomized clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive breast cancer: an intergroup study. J Clin Oncol. 1998 Mar;16(3):994-9.
- Puhalla S, Bhattacharya S, Davidson NE. Hormonal therapy in breast cancer: a model disease for the personalization of cancer care. Mol Oncol. 2012 Apr; 6(2):222-36.
- Wu S, Li Q, Zhu Y, Sun J, Li F, et al. Role of goserelin in combination with endocrine therapy for the treatment of advanced breast cancer in premenopausal women positive for hormone receptor: a retrospective matched case-control study. Cancer biotherapy and pharmaceuticals. Cancer Biother Radiopharm. 2013 Dec; 28 (10): 697-702.
- Ignatiadis M, Buyse M, Sotiriou C. St Gallen International Expert Consensus on the primary therapy of early breast cancer: an invaluable tool for physicians and scientists. Ann Oncol. 2015 Aug; 26 (8):1519-20.
- Moore H., Unger J., Kelly A., et al. Goserelin for Ovarian Protection during Breast-Cancer Adjuvant Chemotherapy NEJM 2015; 372(10): 923-32.
- Lambertini M, Ceppi M, Poggio F, et al. Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies. Ann Oncol. 2015 Dec; 26 (12): 2408-19.
Supplementary files
